An <i>in vitro</i> study on the effect of bevacizumab on endothelial cell proliferation and VEGF concentration level in patients with hereditary hemorrhagic telangiectasia.

Exp Ther Med · 2022 · PMC9366282 · PMID 35978926

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

A positive trend in cell proliferation could also be seen in endothelial cells incubated with 2 and 4 mg/ml Bevacizumab.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.